Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1986
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer
C L Loprinzi, D C Tormey, P Rasmussen, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1986
Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer
F J Cummings, R Gray, T E Davis, et al.
Cancer Treatment Reports
|
June 1, 1982
Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy
S E Vogl, M Pagano, T E Davis, et al.
American Journal of Clinical Oncology
|
December 1, 1982
Toxicity and response criteria of the Eastern Cooperative Oncology Group
M M Oken, R H Creech, D C Tormey, et al.
Cancer
|
July 1, 1976
Further clinical studies with megestrol acetate in advanced breast cancer
F J Ansfield, H L Davis, G Ramirez, et al.
Cancer Research
|
March 1, 1981
Clinical studies of a fast homoarginine-sensitive alkaline phosphatase in patients with cancer
T E Davis, L Kahan, D C Tormey, et al.
Investigational New Drugs
|
January 1, 1990
A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study
D L Trump, J C Marsh, L K Kvols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death
F J Cummings, R Gray, D C Tormey, et al.
American Journal of Clinical Oncology
|
March 10, 2001
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882)
K J Pandya, B Y Yeap, L M Weiner, et al.
Cancer Treatment Reports
|
July 1, 1983
Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion
R H Earhart, J M Koeller, T E Davis, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1986
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer
C L Loprinzi, D C Tormey, P Rasmussen, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1986
Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer
F J Cummings, R Gray, T E Davis, et al.
Cancer Treatment Reports
|
June 1, 1982
Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy
S E Vogl, M Pagano, T E Davis, et al.
American Journal of Clinical Oncology
|
December 1, 1982
Toxicity and response criteria of the Eastern Cooperative Oncology Group
M M Oken, R H Creech, D C Tormey, et al.
Cancer
|
July 1, 1976
Further clinical studies with megestrol acetate in advanced breast cancer
F J Ansfield, H L Davis, G Ramirez, et al.
Cancer Research
|
March 1, 1981
Clinical studies of a fast homoarginine-sensitive alkaline phosphatase in patients with cancer
T E Davis, L Kahan, D C Tormey, et al.
Investigational New Drugs
|
January 1, 1990
A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study
D L Trump, J C Marsh, L K Kvols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death
F J Cummings, R Gray, D C Tormey, et al.
American Journal of Clinical Oncology
|
March 10, 2001
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882)
K J Pandya, B Y Yeap, L M Weiner, et al.
Cancer Treatment Reports
|
July 1, 1983
Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion
R H Earhart, J M Koeller, T E Davis, et al.
Page
of 11